Cargando…
Therapeutic effects of the novel Leucyl-tRNA synthetase inhibitor BC-LI-0186 in non-small cell lung cancer
OBJECTIVE: Leucyl-tRNA synthetase (LRS) is an aminoacyl-tRNA synthetase catalyzing ligation of leucine to its cognate tRNA and is involved in the activation of mTORC1 by sensing cytoplasmic leucine. In this study, the usefulness of LRS as a therapeutic target of non-small cell lung cancer (NSCLC) an...
Autores principales: | Kim, Eun Young, Lee, Jin Gu, Lee, Jung Mo, Kim, Arum, Yoo, Hee Chan, Kim, Kibum, Lee, Minji, Lee, Chulho, Han, Gyoonhee, Han, Jung Min, Chang, Yoon Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535710/ https://www.ncbi.nlm.nih.gov/pubmed/31205503 http://dx.doi.org/10.1177/1758835919846798 |
Ejemplares similares
-
Combination of the LARS1 Inhibitor, BC-LI-0186 with a MEK1/2 Inhibitor Enhances the Anti-Tumor Effect in Non–Small Cell Lung Cancer
por: Lee, Sang Hoon, et al.
Publicado: (2023) -
Control of leucine-dependent mTORC1 pathway through chemical intervention of leucyl-tRNA synthetase and RagD interaction
por: Kim, Jong Hyun, et al.
Publicado: (2017) -
O-GlcNAc modification of leucyl-tRNA synthetase 1 integrates leucine and glucose availability to regulate mTORC1 and the metabolic fate of leucine
por: Kim, Kibum, et al.
Publicado: (2022) -
A Leucyl-tRNA Synthetase Urzyme: Authenticity of tRNA Synthetase Catalytic Activities and Promiscuous Phosphorylation of Leucyl-5′AMP
por: Hobson, Jessica J., et al.
Publicado: (2022) -
Leucyl-tRNA Synthetase Inhibitor, D-Norvaline, in Combination with Oxacillin, Is Effective against Methicillin-Resistant Staphylococcus aureus
por: Lee, Hong-Ju, et al.
Publicado: (2022)